Baxalta Innovations GmbH, now part of Shire
19
0
0
17
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 5/100
10.5%
2 terminated/withdrawn out of 19 trials
89.5%
+3.0% vs industry average
53%
10 trials in Phase 3/4
82%
14 of 17 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (19)
A Study of BAX 888 in Male Adults With Severe Hemophilia A
Role: collaborator
ADVATE/ ADYNOVI Hemophilia A Outcome Database (AHEAD)
Role: collaborator
A Study of TAK-881 in Healthy Adults
Role: collaborator
A Study to Assess the Tolerability, Safety, and Pharmacokinetics of Subcutaneous Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) With Ramp-up and No Ramp-up Dosing in Healthy Adult Participants
Role: collaborator
Efficacy, Safety, Tolerability, Immunogenicity and Pharmacokinetic Evaluation of HYQVIA in Pediatric PIDD Subjects
Role: collaborator
A Safety Study of GAMMAGARD LIQUID (GGL) in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Role: collaborator
FEIBA Reconstitution Volume Reduction and Faster Infusion Study (FEIBA STAR)
Role: collaborator
Post-Authorization Safety, Tolerability and Immunogenicity Evaluation of HyQvia in Pediatric PIDD Subjects
Role: collaborator
RIXUBIS PMS India (RIXUBIS PMS)
Role: collaborator
Prospective and Retrospective, Non-interventional Study to Evaluate the Safety and Effectiveness of Obizur in Real-life Practice
Role: collaborator
BAX 802 in CHA With Inhibitors
Role: collaborator
rVWF IN PROPHYLAXIS
Role: collaborator
Post-Marketing Non-Interventional Safety Evaluation of Obizur in the Treatment of Bleeding Episodes for Patients With Acquired Hemophilia A
Role: collaborator
BAX 855 PK-guided Dosing
Role: collaborator
BAX 855 Continuation
Role: collaborator
Phase 3/4 Study of a Recombinant Protein-Free Factor VIII (rAHF-PFM): Comparison of Continuous Infusion Versus Intermittent Bolus Infusion in Hemophilia A Subjects Undergoing Major Orthopedic Surgery
Role: collaborator
Stage 1 Study of ARALAST NP and GLASSIA in A1PI Deficiency
Role: collaborator
Pregnancy Registry to Collect Long-Term Safety Data From Women Treated With HyQvia
Role: collaborator
Real-world CANadian CUvitru Non-Interventional Study in Subjects Transitioning From Subcutaneous Immunoglobulin (CANCUN)
Role: collaborator
All 19 trials loaded